Atosiban
Inquiry
| Post Date: | Apr 07,2021 |
| Expiry Date: | Apr 07,2022 |
| Detailed Description: |
Cas No. :90779-69-4;914453-95-5
Quantity: 1Kilograms Atosiban is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/oxytocin receptor antagonist (VOTra). Atosiban is indicated to delay imminent pre-term birth in pregnant adult women. Atosiban is useful in improving the pregnancy outcome of in vitro fertilization-embryo transfer (IVF-ET) in patients with repeated implantation failure (RIF). The pregnancy rate improved from zero to 43.7%. https://www.creative-peptides.com/product/atosiban-item-10-101-05-14.html |
| CAS Registry Number: | 90779-69-4;914453-95-5 |
| Synonyms: | Atosiban [USAN:INN];Atosiban (cGMP);Rwj 22164;1-(3-Mercaptopropionic acid)-2-(3-(p-ethoxyphenyl)-D-alanine)-4-L-threonine-8-L-ornithineoxytocin;1-Deamino-2D-tyr-(OEt)-4-thr-8-orn-oxytocin;Atosibanum;Atosibanum [INN-Latin];ORF 22164;Tractocile;UNII-081D12SI0Z;Oxytocin, 1-(3-mercaptopropanoic acid)-2-(O-ethyl-D-tyrosine)-4-L-threonine-8-L-ornithine-;1-({(4R,7S,13S,16R)-7-(2-amino-2-oxoethyl)-13-[(2S)-butan-2-yl]-16-(4-ethoxybenzyl)-10-[(1R)-1-hydroxyethyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-L-prolyl-L-ornithylglycinamide; |
| Molecular Formula: | C43H67N11O12S2 |
| Molecular Weight: | 994.1886 |
| Molecular Structure: | 
|
| Company: | Creative Peptides [ United States ] |
| Contact: | Caroline |
| Tel: | 1-631-624-4882 |
| Fax: | 1-631-614-7828 |
| Email: | contact@creative-peptides.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
